Metabolic Syndrome
Top news of December: Intermittent fasting, MI awareness lacking, new generic apixaban and more
Healio and Cardiology Today present a list of the most-viewed cardiology articles in December. This month, our readers were most interested in benefits of intermittent fasting, the effect of chili pepper consumption on the heart, oral hygiene and CV health, the FDA approval of apixaban generics and more.
Healio’s most-read cardiology news of 2019: Sex disparities, fish oil, DAPA-HF and more
Top diet and nutrition news of 2019: Hydrogel pill, fasting, keto diet medication changes
Intermittent fasting may benefit in metabolic syndrome
New insights on diabetes, CVD research from the TIMI Study Group
Consistent, 10-hour daily eating window benefits adults with metabolic syndrome
LOS ANGELES — Adults with metabolic syndrome, even those prescribed antihypertensive and statin drugs, who consistently limited food and beverage consumption to the same 10-hour period for 12 weeks experienced improvements in body composition, blood pressure and cholesterol levels, according to a speaker at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.
VIDEO: Interconnection between insulin resistance, metabolism requires multidisciplinary attention
Exercise and cardiometabolic health: ‘Never too late to start exercising’
LOS ANGELES — Exercise provides important and varied benefits for individuals with cardiometabolic disorders regardless of experience level, and certain exercise types may yield better outcomes for those with certain conditions, according to a speaker at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.
Insulin resistance meeting features latest research, experts in cardiometabolic health
LOS ANGELES — Experts in the fields of insulin resistance, diabetes, cardiovascular disease, obesity, metabolic syndrome, and liver and kidney disease will lead an international program this week designed to bridge the latest developments across the multiple specialties, explore new research in metabolic diseases and gain new insight on cutting-edge therapeutic discoveries.